Summary The FDA has granted Priority Review to a first-in-class PI3K/mTOR inhibitor for HR-positive, HER2-negative, PIK3CA wild-type advanced breast cancer. This milestone signals a potential shift in second-line treatment options globally, including for patients in Malaysia. FDA Priority Review: The U.S. FDA has accepted the NDA under Priority Review with
Summary For the first time in history, 70% of people diagnosed with cancer now survive at least five years. This global milestone reflects major advances in cancer prevention, early detection, and treatment. Global Survival Breakthrough: According to recent cancer statistics, five-year survival rates have reached 70%, signaling a major shift
Quick Summery Many patients want to know why choose Onco Life Centre for pancreatic cancer treatment in Malaysia. The centre provides trusted, advanced care led by Dr. Christina Ng, with accurate diagnostics, personalized treatment plans, and supportive follow-up that helps patients stay safe and confident at every stage. Expert-Led Care:
Quick Summery A recent study published in 2025 finds that cancer patients who quit smoking within six months of their diagnosis gain nearly one additional year of life. This finding challenges the misconception that quitting after cancer diagnosis is ineffective. The survival benefit applies to all cancer types and stages,
Precision Medicine, AI, and Global Collaboration in Cancer Care Take Center Stage in Berlin Dr. Christina Ng Van Tze, a respected Consultant Medical Oncologist and Medical Director at Onco Life Centre in Bangsar South, Kuala Lumpur, recently represented Malaysia at the ESMO Congress 2025 in Berlin. The global event brought
Quick Read Summary Genetic factors play a significant role in prostate cancer risk, especially for Malaysian men. Family history, inherited gene mutations (like BRCA1, BRCA2, HOXB13), and ethnic-specific variations can increase susceptibility. Understanding these risks enables early detection through regular screening, genetic counseling, and proactive lifestyle choices, improving outcomes and
Quick Read Summary A groundbreaking study reveals how breast cancer’s tumor microenvironment (TME) evolves during chemotherapy. Using single-cell and spatial omics, researchers mapped changes in immune cells, fibroblasts, and blood vessels highlighting how these shifts influence therapy resistance, relapse risk, and opportunities for personalized treatment. Breast tumors act as ecosystems
Quick Read Summary Stage 3 breast cancer is a locally advanced form, meaning it has spread beyond the breast but not to distant organs. The survival rate varies by age, with younger women often facing more aggressive cancers, while middle-aged patients generally have better survival rates. In contrast, older patients
Why Managing Side Effects Matters A breast cancer diagnosis often disrupts every aspect of life. While treatment is essential for combating the disease, it frequently brings a range of side effects that affect physical health, emotions, and daily life. Managing the side effects of breast cancer treatment is vital not
Being diagnosed with stage 2 breast cancer treatment timeline can be scary, but knowing what happens next makes a big difference. At Onco Life Centre, we simplify your care and act fast. Our team arranges tests and gives you results within days. Treatment planning begins right away, and your care
